Schedule 13G ownership disclosure
PROGENICS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 743187106
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,287,200
- Percent of class
- 17.5400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-17-000326
- Form type
- SC 13G
- Filer
- FEDERATED HERMES, INC.
- CIK
- CIK 1056288
- Filed
- Feb 14, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership